Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

39.59 -0.02 (-0.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	682,358
Open	39.66
Bid (Size)	39.45 (1,000)
Ask (Size)	39.70 (100)
Prev. Close	39.61
Today's Range	39.53 - 39.75
52wk Range	10.95 - 40.26
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly ↗

April 27, 2026

Eli Lilly has more to offer than some investors realize.

Via The Motley Fool

Is This $6.3 Billion Deal a Game Changer for Eli Lilly? ↗

April 16, 2026

It's acquiring an asset with a very promising lead drug candidate.

Via The Motley Fool

Performance

YTD	+67.1%	+67.1%
1 Month	+0.2%	+0.2%
3 Month	+68.5%	+68.5%
6 Month	+79.0%	+79.0%
1 Year	+219.5%	+219.5%

More News

Looks Like M&A Week in 3 Different Sectors ↗

April 08, 2026

Via The Motley Fool

Halper Sadeh LLC is Investigating Whether APLS, CNTA, KZR, EQH are Obtaining Fair Deals for their Shareholders

April 07, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

April 07, 2026

From Ademi LLP

Via GlobeNewswire

Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’

April 06, 2026

Via MarketMinute

Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine

April 06, 2026

Via MarketMinute

Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience ↗

April 02, 2026

Via MarketBeat

Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders

April 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Wall Street Ends a Rough Quarter With Its Best Day, Iran Hope Ignites the Rally ↗

April 01, 2026

Via Chartmill

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

March 31, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Why Centessa Stock Soared Today ↗

March 31, 2026

Via The Motley Fool

Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders

March 31, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

March 31, 2026

Via Chartmill

Which stocks are experiencing notable movement on Tuesday? ↗

March 31, 2026

Via Chartmill

The market is filled with gapping stocks in Tuesday's session. ↗

March 31, 2026

Via Chartmill

The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals

March 31, 2026

Via Finterra

The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience

March 31, 2026

Via Finterra

Discover the top movers in Tuesday's pre-market session. ↗

March 31, 2026

Via Chartmill

CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders

March 31, 2026

From Halper Sadeh LLC

Via Business Wire

Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline ↗

February 26, 2026

Via The Motley Fool

Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗

February 23, 2026

Via The Motley Fool

This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗

February 19, 2026

Via The Motley Fool

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

February 03, 2026

From Centessa Pharmaceuticals plc

Via GlobeNewswire

This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally ↗

February 01, 2026

Via The Motley Fool

Frequently Asked Questions

Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?

Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.

What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?

Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?

The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market

What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?

The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 39.59

When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?

The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 05/08/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.